Answers are grounded in this paper and cite their sources.
Voriconazole is a new antifungal agent effective in the treatment of invasive aspergillosis. Interpatient variation in plasma concentrations is considerable--more than 100-fold. We describe 3 patients with diverse manifestations of toxicity (e.g., hallucinations, hypoglycemia, electrolyte disturbance, and pneumonitis) possibly attributable to high voriconazole concentrations. Measurement of plasma concentrations could be helpful in optimizing voriconazole dosages.
No takes yet. Share an insight, caveat, or question.
Boyd et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: